Staidson BioPharm

300204
16.711.88% ( -0.32 )
Delay Trading: Nov 16, 10:49:48

Valuation

Current ValuationThe current P/E ratio is -92.61, within the reasonable range, cheaper than 79.13% of the time in the past 5 years, and the industry ranks 76/84, the industry Median 19.64.

-92.61xP/E
Stock price¥17.03Earnings per share¥-0.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 19.64x
017345168

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 19.64x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
300122SZZHIFEI-BIOL
-2.35x91.91%¥33.15B
688180SHJunshi Biosciences
-71.37x81.90%¥30.60B
603392SHWantai Biological
-63.41x22.02%¥28.89B
300676SZBGI Genomics
-28.14x118.23%¥15.34B
688520SHSinocelltech
-14.57x171.21%¥13.95B
688765SHHEALTHGEN BIOTECH
-92.77x--¥13.14B
688319SHOlymvax Biopharmaceuticals
-337.79x227.87%¥10.82B
688806SHTrinomab Pharmaceutical
-22.46x--¥10.12B
688137SHNovoprotein
-97.24x--¥9.42B
688443SHGenrix Bio
-44.33x77.40%¥9.28B
300204SZStaidson BioPharm
-92.61x--¥9.22B
688062SHMabwell
-8.64x37.63%¥9.07B
688382SHInventisBio
-20.14x5.45%¥7.64B
688759SHBeBetter Med
-36.91x12.50%¥7.30B
002030SZDAJY
-9.80x--¥7.28B
688177SHBIO-THERA
-15.70x2.47%¥6.92B
300294SZBOYA BIOLOGY
-39.97x306.82%¥6.71B
688276SHBCHT
-31.96x66.67%¥6.39B
002038SZSL PHARM
-6.16x--¥5.17B
688221SHFroniter Biotechnologies
-137.77x--¥4.93B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.